LMNA and lung adenocarcinoma: A strong reduction in lamin A but not in lamin C expression was specifically observed in 12 (37.5%) patients with lung adenocarcinoma pleural metastasis using a mouse anti-lamin A/C antibody (Jol2) (Panel A in Fig 1 and S1 Fig).